Keyword "INHIBITOR OF ARGINASE II" found in the following publications:

• APPROACHES TO CORRECTION OF ISCHEMIC AND REPERFUSION KIDNEY INJURIES IN EXPERIMENT

  Background: Acute kidney injury is an urgent health problem at the junction of specialties with a high level ...

  Abstract | Full text (PDF)

• CORRECTION OF ADMA-INDUCED PREECLAMPSIA WITH THE USE OF PHOSPHODIESTERASE 5 AND SELECTIVE INHIBITOR OF ARGINASE II ZB49-0010

  Simulation experimental ADMA-like preeclampsia was carried out by administering the rats with L-NAME during 14-20 days of pregnancy. In animals, ...

  Abstract | Full text (PDF)

• STUDY OF THE EFFECT OF SELECTIVE INHIBITOR OF ARGINASE II KUD 975 AND OF LOW DOSES OF ACETYLSALICYLIC ACID ON THE FUNCTIONAL PARAMETERS OF THE CARDIOVASCULAR SYSTEM IN EXPERIMENTAL PREECLAMPSIA

  Introduction: Over the past decade, preeclampsia has been the subject of an increased attention, as this complication is the most ...

  Abstract | Full text (PDF)

• М

  This paper deals with the study of endothelio- and cardioprotective activity of arginase II selective inhibitor, the substance under the ...

  Abstract | Full text (PDF)

• CORRECTION OF MORPHOFUNCTIONAL DISORDERS WITH ASIALOERYTHROPOIETIN AND SELECTIVE INHIBITOR OF ARGINASE II KUD975 IN CASES OF ISCHEMIC KIDNEY DAMAGE IN THE EXPERIMENT

  Introduction: Acute kidney injury (AKI), which is based on ischemic-reperfusion damage, is a widespread life-threatening condition and remains a serious ...

  Abstract | Full text (PDF)